The Ripple Effect of Regulations: Cosmetic Regulation (EC) No. 1223/2009 Amendments

On August 15, 2023, amendments to the European Union’s Cosmetic Regulation (EC) No. 1223/2009 will take effect. Among these amendments is an update to fragrance allergens listed in Annex III, which adds 56 new substances. Although these amendments are specific to an EU regulation, products sold into the state of California may be impacted. California’s [...]

2023-08-10T18:20:25+00:00EPA|

EPA Releases Draft Guidance to Expand Availability of Virus Claims to Additional Antimicrobial Products 

On July 17, 2023, EPA released for public comment its Draft Guidance for the Evaluation of Products for Claims Against Viruses. This draft guidance outlines the pathway and testing requirements for food and non-food contact sanitizer products to make claims against viruses. Historically, a sanitizer has not been eligible for virucidal claims unless it was [...]

2023-07-24T20:46:52+00:00EPA|

EPA Extends Emerging Viral Pathogens Policy for Rabbit Hemorrhagic Disease Virus (RHDV2) Indefinitely

UPDATE: On July 27, 2023, EPA updated the Emerging Viral Pathogens Policy web page with the indefinite extension of the EVP policy for Rabbit Hemorrhagic Disease Virus (RHDV2). In July 2020, EPA triggered its Emerging Viral Pathogens Policy (EVP) to allow off-label claims against Rabbit Hemorrhagic Disease Virus (RHDV2) to address the U.S. outbreak of [...]

2023-07-27T19:42:21+00:00EPA|

EPA Triggers Emerging Viral Pathogens Policy for Marburg Virus

In response to recent simultaneous outbreaks of Marburg virus in Tanzania and Equatorial Guinea the United States EPA has engaged the Emerging viral Pathogens Policy (EVP). The Ministry of Health and Social Welfare for Equatorial Guinea first announced the outbreak on February 7, 2023. Since the announcement, 15 cases and 11 deaths have been confirmed [...]

EPA Triggers Emerging Viral Pathogens Policy for Ebola Virus

Due to the ongoing Ebola outbreak in Uganda, the United States EPA has engaged its Emerging viral Pathogens Policy (EVP). The current outbreak of Ebola Virus Disease is caused by infection with Sudan ebolavirus. The first confirmed case was identified in a 25-year-old male in the Mubende District of Uganda on September 19th; though it [...]

Canada Issued Emerging Viral Pathogens Policy for Monkeypox Virus

On July 23rd, 2022, the World Health Organization (WHO) declared the recent outbreak of Monkeypox virus “a public health emergency of international concern”.(1) This announcement has come following the continued worldwide spread of Monkeypox from 92 cases in 12 member countries reported in May to over 16,000 confirmed cases and 5 deaths in 75 member [...]

2022-10-19T19:40:51+00:00EPA, State|

The Path to Making Off-Label Disinfection Claims Against SARS-CoV-2 on EPA-Registered Products

Upon the outbreak of Coronavirus Disease 2019 (COVID-19), consumers were instructed by the Centers for Disease Control and Prevention (CDC) to protect themselves and their families by washing their hands with soap and water for at least 20 seconds or utilizing a hand sanitizer containing at least 60% alcohol when handwashing is not available.  CDC [...]

Frequently Asked Questions: COVID-19 Regulatory Pathways

In response to the COVID-19 pandemic, caused by a novel coronavirus SARS-CoV-2, the US EPA has announced certain streamlined processes for some disinfectant products. It is important to understand whether your product qualifies for any of these pathways, and what the associated requirements are. New Registrations  Does a new disinfectant or antimicrobial product qualify for [...]